Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Abstract Background Evidence and guidelines for Non-vitamin K antagonist oral anticoagulants (NOACs) use when prescribing concurrent rifampin for tuberculosis treatment in patients with non-valvular atrial fibrillation (NVAF) are limited. Methods Using the Korean National Health Insurance Service da...
Main Authors: | Ki Won Hwang, Jin Hee Choi, Soo Yong Lee, Sang Hyun Lee, Min Ku Chon, Jungkuk Lee, Hasung Kim, Yong-Giun Kim, Hyung Oh Choi, Jeong Su Kim, Yong-Hyun Park, June Hong Kim, Kook Jin Chun, Gi-Byoung Nam, Kee-Joon Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-023-03212-z |
Similar Items
-
Investigation of Rifampin Serum Levels in Patients Diagnosed with Tuberculosis Treated with the Drug Regimen Mazandaran, 2020-2021
by: Lotfollah Davoodi, et al.
Published: (2023-11-01) -
Synergism of Linezolid and Rifampin to Combat Multidrug-Resistant Environmental Enterococci Isolates
by: Mobina Noori, et al.
Published: (2022-08-01) -
Repurposing 9-Aminoacridine as an Adjuvant Enhances the Antimicrobial Effects of Rifampin against Multidrug-Resistant Klebsiella pneumoniae
by: Pengfei She, et al.
Published: (2023-06-01) -
Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal
by: Yu Xiong, et al.
Published: (2023-11-01) -
Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay
by: Raquel de A Maschmann, et al.
Published: (2011-03-01)